Peter Gleason, MD, found himself in handcuffs recently for promoting an off-label use of a drug, according to this article in the New York Times. He is charged with promoting Xyrem, a narcolepsy drug from Jazz Pharmaceuticals, for depression and pain relief, and getting paid by the company to do it. The doc says he's covered by FDA rules and the First Amendment, the prosecuter says "he conspired with the drug manufacturer to recommend it for potentially dangerous uses."
This is one to keep an eye on. If I were the CME provider involved in this, I would be sweating bullets—could they not also be accused of misconduct on this one?
0 comments
Hide comments
